Consecutive Daily Administration of Intratracheal Surfactant and Human Umbilical Cord-Derived Mesenchymal Stem Cells Attenuates Hyperoxia-Induced Lung Injury in Neonatal Rats

0
9
The authors evaluated the effects of two consecutive days of intratracheal administration of surfactant and human umbilical cord-mesenchymal stem cells on hyperoxia-induced lung injury.
[Stem Cell Research & Therapy]
Chou, H.-C., Chang, C.-H., Chen, C.-H., Lin, W., & Chen, C.-M. (2021). Consecutive daily administration of intratracheal surfactant and human umbilical cord-derived mesenchymal stem cells attenuates hyperoxia-induced lung injury in neonatal rats. Stem Cell Research & Therapy, 12(1), 258. https://doi.org/10.1186/s13287-021-02335-4 Cite
Full Article